National Bank of Canada
FEED

National Bank of Canada’s ENvue Medical Inc FEED Stock Holding History

National Bank of Canada’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$122 – 2854
2023
Q4 		$122 Hold
1
– – ﹤0.01% 2651
2023
Q3 		$190 Buy
+1
New +$298 ﹤0.01% 2698

Other funds holding FEED

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AFS
Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Bank of Canada's FEED Position: Q1 2024 in Review

National Bank of Canada sold out of ENvue Medical Inc (FEED) in Q1 2024, closing a stake of 1 share — an estimated $122 sold.

National Bank of Canada first reported a position in FEED in Q3 2023 and held it in 2 quarters. The position peaked at $190 in Q3 2023. 7 funds tracked by Wall St. Rank hold FEED as of Q1 2024.

  • National Bank of Canada reported no remaining ENvue Medical Inc position as of Q1 2024 after selling out during the quarter.
  • National Bank of Canada sold 1 ENvue Medical Inc share in Q1 2024, an estimated $122.
  • National Bank of Canada first reported a position in ENvue Medical Inc in Q3 2023 and held it in 2 quarters.
  • National Bank of Canada's ENvue Medical Inc position peaked at $190 in Q3 2023.
  • 7 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2024.

Based on National Bank of Canada's 13F filing for Q1 2024, filed 13 May 2024.